Intense crosstalk between TLRs and the inflammasome pathway has been described in neurodegenerative diseases since the TLR activation acts as a priming signal for the expression of NLRP3, pro-IL-18, and pro-IL-1β. This evidence concerns the gene NLRP3 and neurodegenerative disease.